ASP Isotopes (NASDAQ:ASPI) Stock: Insider Robert John Andrew Ryan Purchases 15,000 Shares

ASP Isotopes Inc. (NASDAQ:ASPI) Director John Ryan bought 15,000 shares of the business’s stock in a transaction dated Wednesday, September 30th. The shares were bought at an average cost of $2.68 per share, for a total transaction of $40,200.00. Following the completion of the transaction, the director directly owned 675,222 shares of the company’s stock, valued at $1,809,594.96. This trade represents a 2.27% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.

Robert John Andrew Ryan also recently made the following trade(s):

• On Monday, September 28th, John Ryan purchased 8,000 shares of ASP Isotopes stock. The stock was bought at an average cost of $2.70 per share, for a total transaction of $21,600.00.

ASP Isotopes Trading Up 1.9%

NASDAQ ASPI traded up $0.05 on Thursday, hitting $2.70. 5,479,989 shares of the company were exchanged, compared to its average volume of 4,790,329. The company’s 50 day moving average price is $3.75 and its 200-day moving average price is $4.91. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.87 and a quick ratio of 3.85. The firm has a market capitalization of $413.94 million, a P/E ratio of -2.05 and a beta of 3.59. ASP Isotopes Inc. has a twelve month low of $2.51 and a twelve month high of $14.49.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings data on Friday, August 14th. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.11). ASP Isotopes had a negative net margin of 427.98% and a negative return on equity of 64.99%. The firm had revenue of $5.12 million for the quarter, compared to analysts’ expectations of $4.47 million.

Hedge Funds Weigh In On ASP Isotopes

A number of large investors have recently made changes to their positions in the business. WINTON GROUP Ltd purchased a new stake in shares of ASP Isotopes in the second quarter worth approximately $588,000. Integrated Wealth Concepts LLC purchased a new position in ASP Isotopes during the second quarter valued at approximately $176,000. Squarepoint Ops LLC increased its stake in ASP Isotopes by 75.6% in the 2nd quarter. Squarepoint Ops LLC now owns 123,951 shares of the company’s stock valued at $771,000 after buying an additional 53,354 shares during the period. Amundi acquired a new position in ASP Isotopes in the 2nd quarter valued at approximately $107,000. Finally, AXQ Capital LP acquired a new position in ASP Isotopes in the 2nd quarter valued at approximately $80,000. Institutional investors and hedge funds own 16.80% of the company’s stock.

Analyst Upgrades and Downgrades

ASPI has been the subject of several research analyst reports. Wall Street Zen upgraded shares of ASP Isotopes from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 22nd. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research report on Monday, September 21st. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $13.00.

About ASP Isotopes

ASP Isotopes Inc (NASDAQ: ASPI) is a development-stage company focused on isotope enrichment and related technologies. The company is developing an isotope-separation platform known as the Aerodynamic Separation Process, which is intended to enrich selected chemical elements and isotopes for use in several specialized markets.

ASP Isotopes has identified applications in the nuclear energy, medical, semiconductor, and quantum-computing industries. Its development programs have included uranium enrichment as well as the production of specialty isotopes such as carbon-14, molybdenum-100, and silicon-28.